Jubilant Agri and Consumer Products Limited has informed the Exchange that the Board of Directors of the Company, at its meeting held today, i.e. November 04, 2025, has considered the recommendation of Independent Directors and Audit Committee and approved the Scheme of Arrangement for demerger between Jubilant Agri and Consumer Products Limited ( The Company or Demerged Company ) and Jubilant Agri Solutions Limited ( JASL / Resulting Company ) and their respective shareholders and creditors, under the provisions of section 230-232 and other applicable provisions of the Companies Act, 2013 and the Rules made thereunder ( Scheme ).
JUBLCPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.7 pts more than Nifty Microcap 250 and 6.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Jubilant Agri and Consumer Products Limited (JACPL) has approved a Scheme of Arrangement to demerge its Agri Division into Jubilant Agri Solutions Limited (JASL), a wholly owned subsidiary. The Agri Division, which makes fertilizers, crop nutrition products, bio-stimulants and plant growth regulators, contributed Rs. 4,568 million in turnover in FY25, or 29.65% of JACPL's standalone revenue. Shareholders of JACPL will receive 1 equity share of JASL (face value Rs. 10) for every 1 share held in JACPL, creating a mirror shareholding structure. The new entity JASL will seek listing on BSE and NSE. The scheme still needs approvals from shareholders, creditors, SEBI, stock exchanges, and the NCLT before it becomes effective.
Shareholders of JACPL will end up holding shares in two listed entities instead of one, with the Agri business spun out into a separate company. The move is aimed at unlocking value by letting each business attract investors suited to its own risk-return profile, though the demerger is still subject to multiple regulatory approvals and will take time to complete.